Literature DB >> 17215884

Shedding light on drug transport: structure and function of the P-glycoprotein multidrug transporter (ABCB1).

Frances J Sharom1.   

Abstract

P-glycoprotein (Pgp; ABCB1), a member of the ATP-binding cassette (ABC) superfamily, exports structurally diverse hydrophobic compounds from the cell, driven by ATP hydrolysis. Pgp expression has been linked to the efflux of chemotherapeutic drugs in human cancers, leading to multidrug resistance (MDR). The protein also plays an important physiological role in limiting drug uptake in the gut and entry into the brain. Substrates partition into the lipid bilayer before interacting with Pgp, which has been proposed to function as a hydrophobic vacuum cleaner. Low- and medium-resolution structural models of Pgp suggest that the 2 nucleotide-binding domains are closely associated to form a nucleotide sandwich dimer. Pgp is an outwardly directed flippase for fluorescent phospholipid and glycosphingolipid derivatives, which suggests that it may also translocate drug molecules from the inner to the outer membrane leaflet. The ATPase catalytic cycle of the protein is thought to proceed via an alternating site mechanism, although the details are not understood. The lipid bilayer plays an important role in Pgp function, and may regulate both the binding and transport of drugs. This review focuses on the structure and function of Pgp, and highlights the importance of fluorescence spectroscopic techniques in exploring the molecular details of this enigmatic transporter.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17215884     DOI: 10.1139/o06-199

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  32 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  Future Perspectives for Brain Pharmacotherapies: Implications of Drug Transport Processes at the Blood-brain Barrier.

Authors:  Dirk M Hermann
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 3.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Identification of the distance between the homologous halves of P-glycoprotein that triggers the high/low ATPase activity switch.

Authors:  Tip W Loo; David M Clarke
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 5.  Mechanisms of drug resistance in colon cancer and its therapeutic strategies.

Authors:  Tao Hu; Zhen Li; Chun-Ying Gao; Chi Hin Cho
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

6.  Cancer-relevant biochemical targets of cytotoxic Lonchocarpus flavonoids: a molecular docking analysis.

Authors:  Caitlin E Cassidy; William N Setzer
Journal:  J Mol Model       Date:  2009-07-15       Impact factor: 1.810

7.  Transmembrane passage of hydrophobic compounds through a protein channel wall.

Authors:  Elizabeth M Hearn; Dimki R Patel; Bryan W Lepore; Mridhu Indic; Bert van den Berg
Journal:  Nature       Date:  2009-02-01       Impact factor: 49.962

8.  Phorbol 12-myristate 13-acetate inhibits P-glycoprotein-mediated efflux of digoxin in MDCKII-MDR1 and Caco-2 cell monolayer models.

Authors:  Yu-hua Li; Hui-chang Bi; Ling Huang; Jing Jin; Guo-ping Zhong; Xu-nian Zhou; Min Huang
Journal:  Acta Pharmacol Sin       Date:  2013-12-23       Impact factor: 6.150

9.  MRP isoforms and BCRP mediate sulfate conjugate efflux out of BeWo cells.

Authors:  Pallabi Mitra; Kenneth L Audus
Journal:  Int J Pharm       Date:  2009-09-25       Impact factor: 5.875

10.  Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity.

Authors:  Fijs W B van Leeuwen; Tessa Buckle; Ariena Kersbergen; Sven Rottenberg; Kenneth G A Gilhuijs
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-12-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.